328 related articles for article (PubMed ID: 20444913)
1. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia.
Bonifacio E; Yu L; Williams AK; Eisenbarth GS; Bingley PJ; Marcovina SM; Adler K; Ziegler AG; Mueller PW; Schatz DA; Krischer JP; Steffes MW; Akolkar B
J Clin Endocrinol Metab; 2010 Jul; 95(7):3360-7. PubMed ID: 20444913
[TBL] [Abstract][Full Text] [Related]
2. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
[TBL] [Abstract][Full Text] [Related]
3. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of early subclinical somatic neuropathy in children and adolescents with Type 1 diabetes mellitus and its association with the persistence of autoantibodies to glutamic acid decarboxylase (GAD) and islet antigen-2 (IA-2).
Louraki M; Katsalouli M; Kanaka-Gantenbein C; Kafassi N; Critselis E; Kallinikou D; Tsentidis C; Karavanaki K
Diabetes Res Clin Pract; 2016 Jul; 117():82-90. PubMed ID: 27329026
[TBL] [Abstract][Full Text] [Related]
5. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2.
Törn C; Mueller PW; Schlosser M; Bonifacio E; Bingley PJ;
Diabetologia; 2008 May; 51(5):846-52. PubMed ID: 18373080
[TBL] [Abstract][Full Text] [Related]
6. Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories.
Bingley PJ; Williams AJ; Colman PG; Gellert SA; Eisenbarth G; Yu L; Perdue LH; Pierce JJ; Hilner JE; Nierras C; Akolkar B; Steffes MW;
Clin Trials; 2010; 7(1 Suppl):S56-64. PubMed ID: 20693189
[TBL] [Abstract][Full Text] [Related]
7. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
[TBL] [Abstract][Full Text] [Related]
8. Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives.
Wang JP; Zhou ZG; Lin J; Huang G; Zhang C; Yang L; Yuan Y; Zhou HF; Zhou M; Hou C; Zhou WD; Peng H; Hagopian WA
Tissue Antigens; 2007 Nov; 70(5):369-75. PubMed ID: 17919266
[TBL] [Abstract][Full Text] [Related]
9. Islet autoantibodies present in association with Ljungan virus infection in bank voles (Myodes glareolus) in northern Sweden.
Warvsten A; Björnfors M; Arvidsson M; Vaziri-Sani F; Jönsson I; Olsson GE; Ahlm C; Larsson HE; Lernmark Å; Nilsson AL
J Med Virol; 2017 Jan; 89(1):24-31. PubMed ID: 27283793
[TBL] [Abstract][Full Text] [Related]
10. Seroconversion to islet autoantibodies between early pregnancy and delivery in non-diabetic mothers.
Lindehammer SR; Hansson I; Midberg B; Ivarsson SA; Lynch KF; Dillner J; Lernmark A;
J Reprod Immunol; 2011 Jan; 88(1):72-9. PubMed ID: 21111487
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
[TBL] [Abstract][Full Text] [Related]
12. Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes.
Genovese S; Bazzigaluppi E; Gonçalves D; Ciucci A; Cavallo MG; Purrello F; Anello M; Rotella CM; Bardini G; Vaccaro O; Riccardi G; Travaglini P; Morenghi E; Bosi E; Pozzilli P
Eur J Endocrinol; 2006 Mar; 154(3):441-7. PubMed ID: 16498058
[TBL] [Abstract][Full Text] [Related]
13. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5.
Xiang Y; Huang G; Shan Z; Pan L; Luo S; Yang L; Shi L; Li Q; Leslie RD; Zhou Z
Acta Diabetol; 2015 Dec; 52(6):1121-7. PubMed ID: 26239144
[TBL] [Abstract][Full Text] [Related]
14. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
[TBL] [Abstract][Full Text] [Related]
15. Comparison of measurements of autoantibodies to glutamic acid decarboxylase and islet antigen-2 in whole blood eluates from dried blood spots using the RSR-enzyme linked immunosorbent assay kits and in-house radioimmunoassays.
Persson A; Becker C; Hansson I; Nilsson A; Törn C
Exp Diabetes Res; 2010; 2010():173652. PubMed ID: 20613950
[TBL] [Abstract][Full Text] [Related]
16. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome.
Morgenthaler NG; Seissler J; Achenbach P; Glawe D; Payton M; Meinck HM; Christie MR; Scherbaum WA
Autoimmunity; 1997; 25(4):203-11. PubMed ID: 9344328
[TBL] [Abstract][Full Text] [Related]
18. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
[TBL] [Abstract][Full Text] [Related]
19. Environmental factors related to the induction of beta-cell autoantibodies in 1-yr-old healthy children.
Wahlberg J; Fredriksson J; Nikolic E; Vaarala O; Ludvigsson J;
Pediatr Diabetes; 2005 Dec; 6(4):199-205. PubMed ID: 16390388
[TBL] [Abstract][Full Text] [Related]
20. A simple screening method for individuals at risk of developing type 1 diabetes: measurement of islet cell autoantibodies (GADA, IA-2A, and IAA) on dried capillary blood spots collected on filter paper.
Siraj ES; Rogers DG; Gupta MK; Reddy SS
Horm Metab Res; 2012 Oct; 44(11):855-60. PubMed ID: 22893260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
